Nicholson RI - Search Results

1

Expression of androgen receptor and growth factors in premalignant lesions of the prostate.

Harper ME, Glynne-Jones E, Goddard L, Mathews P, Nicholson RI. Harper ME, et al. Among authors: nicholson ri. J Pathol. 1998 Oct;186(2):169-77. doi: 10.1002/(SICI)1096-9896(1998100)186:2<169::AID-PATH164>3.0.CO;2-W. J Pathol. 1998. PMID: 9924433

2

Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.

Hutcheson IR, Goddard L, Barrow D, McClelland RA, Francies HE, Knowlden JM, Nicholson RI, Gee JM. Hutcheson IR, et al. Among authors: nicholson ri. Breast Cancer Res. 2011 Mar 11;13(2):R29. doi: 10.1186/bcr2848. Breast Cancer Res. 2011. PMID: 21396094 Free PMC article.

3

Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells.

Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JM, Harper ME, Barrow D, Wakeling AE, Nicholson RI. Knowlden JM, et al. Among authors: nicholson ri. Endocrinology. 2003 Mar;144(3):1032-44. doi: 10.1210/en.2002-220620. Endocrinology. 2003. PMID: 12586780

4

Extreme growth factor signalling can promote oestrogen receptor-alpha loss: therapeutic implications in breast cancer.

Gee JM, Giles MG, Nicholson RI. Gee JM, et al. Among authors: nicholson ri. Breast Cancer Res. 2004;6(4):162-3. doi: 10.1186/bcr904. Epub 2004 Jun 9. Breast Cancer Res. 2004. PMID: 15217488 Free PMC article. No abstract available.

5

Analysis of the level of mRNA expression of the membrane regulators of complement, CD59, CD55 and CD46, in breast cancer.

Rushmere NK, Knowlden JM, Gee JM, Harper ME, Robertson JF, Morgan BP, Nicholson RI. Rushmere NK, et al. Among authors: nicholson ri. Int J Cancer. 2004 Mar 1;108(6):930-6. doi: 10.1002/ijc.11606. Int J Cancer. 2004. PMID: 14712499

6

Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination.

Nicholson RI, Hutcheson IR, Knowlden JM, Jones HE, Harper ME, Jordan N, Hiscox SE, Barrow D, Gee JM. Nicholson RI, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):346S-54S. doi: 10.1158/1078-0432.ccr-031206. Clin Cancer Res. 2004. PMID: 14734490

7

Expression of luminal and basal cytokeratins in human breast carcinoma.

Abd El-Rehim DM, Pinder SE, Paish CE, Bell J, Blamey RW, Robertson JF, Nicholson RI, Ellis IO. Abd El-Rehim DM, et al. Among authors: nicholson ri. J Pathol. 2004 Jun;203(2):661-71. doi: 10.1002/path.1559. J Pathol. 2004. PMID: 15141381

8

The biology of antihormone failure in breast cancer.

Nicholson RI, Gee JM, Knowlden J, McClelland R, Madden TA, Barrow D, Hutcheson I. Nicholson RI, et al. Breast Cancer Res Treat. 2003;80 Suppl 1:S29-34; discussion S35. doi: 10.1023/a:1025467500433. Breast Cancer Res Treat. 2003. PMID: 14535532 Review.

9

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization.

Gee JM, Nicholson RI. Gee JM, et al. Among authors: nicholson ri. Breast Cancer Res. 2003;5(3):126-9. doi: 10.1186/bcr584. Epub 2003 Feb 20. Breast Cancer Res. 2003. PMID: 12793892 Free PMC article. Review.

10

Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitor.

Harper ME, Goddard L, Glynne-Jones E, Assender J, Dutkowski CM, Barrow D, Dewhurst OL, Wakeling AE, Nicholson RI. Harper ME, et al. Among authors: nicholson ri. Prostate. 2002 Jun 1;52(1):59-68. doi: 10.1002/pros.10069. Prostate. 2002. PMID: 11992620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results